Font Size: a A A
Keyword [Chimeric antigen receptor T cells]
Result: 1 - 20 | Page: 1 of 3
1. Clinical And In Vitro Study On The Anti Leukemia Effect Of Chimeric Antigen Receptor T Cells
2. PSCA And MUC1 In Non-small-cell Lung Cancer As Targets Of Chimeric Antigen Receptor T Cells
3. A Preliminary Study Of PD-1-antibody-expressing,Chimeric Antigen-receptor T Cells Targeting Mesothelin In Patients With Malignant Biliary Tumors
4. Research Progress On The Application Of Immunotherapy In Multiple Myeloma
5. Cytotoxic Effect And Optimization Of Different Antigen Epitope Of CD30-targeted Chimeric Antigen Receptor T Cells In Classical Hodgkin's Lymphoma Cell Line
6. The Study Of CD123 On The Prognosis Of Acute Myeloid Leukemia And The In Vitro Cytotoxicity By Chimeric Antigen Receptor T Cells Targeting CD123
7. The Antitumor Effects Of CAR-T Cells Targeting EpCAM Antigen On Colorectal Cancer
8. Fabrication Of C-Met Chimeric Antigen Receptor T Cells And Killing Of Hepatocellular Carcinoma Cells In Vitro And In Vivo
9. Construction And Characterization Of CAR-T Cells Targeting GPC3-Positive Hepatocellular Carcinoma
10. Analysis Of The Effect Of CAR-T Cells In Treatment Of Recurrent Refractory DLBCL
11. Antitumor Effect And Mechanism Of Targeting CD105 Chimeric Antigen Receptor T Cells
12. Antitumor Efficacy Of NKG2D CAR-T Cells Against Human Colorectal Cancer Cells In Vitro And In Vivo
13. Study On UPAR In The Metastasis Of Ovarian Cancer And Anti-uPAR Chimeric Antigen Receptor Against Ovarian Cancer
14. New Strategies To Improve The Safety And Efficacy Of CART In Hematological Malignancies
15. Construction And Application Of Nursing Program For Cytokine Release Syndrome In Patients With Hematologic Malignancies Treated By Chimeric Antigen Receptor T Cells
16. The Characteristics Of SSEA4~+ HUC-MSC And The Role And Mechanism Of HUC-MSC Expressing T Cell Costimulatory Molecules In Tumor Therapy
17. Function And Mechanistic Study Of Novel Bi-affinity CAR T Cells Targeting CD19 And PDL1
18. The Study On Efficacy And Correlative Factors Of CD19 Chimeric Antigen Receptor T Cells Therapy In Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
19. The Cytotoxicity Of Anti-EGFR Chimeric Antigen Receptor T Cells For Glioma Cell Lines
20. Preparation Of BCL2/IGH-CAR T Cells And Its Biological Effects In Vitro
  <<First  <Prev  Next>  Last>>  Jump to